Episodes

  • Epstein-Barr Virus Antibodies and Multiple Sclerosis

    Epstein-Barr Virus Antibodies and Multiple Sclerosis
    Mar 9 2026

    Interview with Hannes Vietzen, PhD, author of Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases
    Show More Show Less
    15 mins
  • Comparative Effectiveness of Brivaracetam, Cenobamate,Lacosamide, and Perampanel in Focal Epilepsy

    Comparative Effectiveness of Brivaracetam, Cenobamate,Lacosamide, and Perampanel in Focal Epilepsy
    Feb 9 2026

    Interview with Emanuele Cerulli Irelli, MD, PhD, author of Comparative Effectiveness of Brivaracetam, Cenobamate,Lacosamide, and Perampanel in Focal Epilepsy. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy
    Show More Show Less
    17 mins
  • US Burden of Disorders Affecting the Nervous System

    US Burden of Disorders Affecting the Nervous System
    Nov 24 2025

    Interview with John P. Ney, MD, MPH, author of US Burden of Disorders Affecting the Nervous System: From the Global Burden of Disease 2021 Study. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • US Burden of Disorders Affecting the Nervous System
    Show More Show Less
    24 mins
  • Hemorrhage and Risk Factors in Unruptured Brain AVM

    Hemorrhage and Risk Factors in Unruptured Brain AVM
    Oct 6 2025

    Interview with Helen Kim, PhD, author of Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations: The Multicenter Arteriovenous Malformation Research Study (MARS). Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations
    Show More Show Less
    17 mins
  • Intravenous Argatroban or Eptifibatide and Mechanical Thrombectomy

    Intravenous Argatroban or Eptifibatide and Mechanical Thrombectomy
    Aug 18 2025

    Interview with Colin P. Derdeyn, MD, author of Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy
    Show More Show Less
    19 mins
  • GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension

    GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
    Jul 14 2025

    Interview with Dennis J. Rivet II, MD, author of GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
    Show More Show Less
    22 mins
  • Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome

    Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
    Jun 2 2025

    Interview with Manuel Comabella, MD, author of Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
    Show More Show Less
    14 mins
  • Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

    Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
    May 5 2025

    Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder
    Show More Show Less
    21 mins